CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111.4 CNY | +1.86% |
|
-5.48% | -23.58% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Changchun High-Tech Industry (Group) Inc. specializes in the manufacturing and marketing of biopharmaceutical products. Products include polyethylene glycol-based recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, lyophilized live varicella vaccines and rabies vaccines for human use.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
111.4
CNY
Average target price
195.3
CNY
Spread / Average Target
+75.32%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.58% | 6.07B | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B |
- Stock Market
- Equities
- 000661 Stock
- News Changchun High-Tech Industry (Group) Co., Ltd.
- Changchun's Clinical Trial For EG017 Tablets Gets Regulatory Approval
